We show here that families of 3 or more diagnosed melanomas accounted for less than 8% of familial melanoma, which together with the above data suggest that CDKN2A mutations are likely to be, at most, a minor contributor to the present findings on discordant cancers. The gene discussed is CDKN2A; the disease is cancer.